Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$26.08 – $37.61
14% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $500.6M | $662.5M | $1.85B | $1.90B | $3.15B | $7.06B | $5.72B | $6.16B |
| Cost of revenue | $255.1M | $354.8M | $1.20B | $1.33B | $1.45B | $2.46B | $2.90B | $3.24B |
| Gross profit | $245.5M | $307.7M | $657.3M | $570.3M | $1.70B | $4.60B | $2.82B | $2.92B |
| Gross margin | 49.0% | 46.5% | 35.5% | 30.1% | 54.0% | 65.2% | 49.3% | 47.4% |
| R&D | $386.3M | $409.3M | $341.4M | $399.2M | $1.18B | $2.35B | $862.5M | $772.2M |
| Operating income | −$319.5M | −$316.4M | $449.6M | −$263.3M | −$3.8M | $1.50B | $939.8M | $918.7M |
| EBITDA | −$300.5M | −$269.2M | $819.1M | $85.3M | $395.4M | $2.14B | $1.67B | $1.63B |
| Net income | −$361.9M | −$346.8M | $277.5M | −$464.8M | −$347.4M | $1.48B | $988.0M | $1.37B |
| Net margin | -72.3% | -52.3% | 15.0% | -24.5% | -11.0% | 20.9% | 17.3% | 22.3% |
| EPS (diluted) | -8.88 | -8.50 | 5.13 | -7.37 | -4.93 | 19.23 | 12.60 | 17.61 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $5.5B | $10.67 | $10.22–$10.99 | 1 |
| 2027 | $5.5B | $10.66 | $10.22–$10.98 | 1 |
| 2028 | $5.9B | $13.83 | $13.25–$14.25 | 1 |
| 2029 | $6.2B | $14.13 | $13.54–$14.55 | 1 |
Forward consensus · source: Financial Modeling Prep
BAVARIAN NORDIC A S
No one on the platform currently holds BVNKF.
No tracked institution reports a position in BVNKF as of their last filing.
No one on the platform has traded BVNKF yet.
| $1.3B |
| — |
| HYPMYHypera S.A. | $4.21 | +2.43% | $3.0B | — |
| MAHLYMediPal Holdings Corporation | $16.28 | +0.00% | $3.3B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 1.7× earnings vs its 1.6× historical median P/E.
Fair value ≈ $27.43 · price $27.69 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.